Buy Hikma Pharmaceuticals (HIK) by Suraj Radhakrishnan in The Motley Fool CLOSED
-
Performance
-21.10%
-
Price at start
2,467.00p
(ask)
-
Price at close
1,873.00p
(bid)
-
Tip made
02/11/2021
-
Tip Status
Closed
04/11/2024
Icon Key:
Tip Notes
"...the company looks like a good long-term investment for my portfolio and operates in a sector that I think will remain crucial. It’s on my FTSE 100 shares to buy list for November." - Suraj Radhakrishnan, The Motley Fool
View Tip Research
NOTE: Stockomendation Ltd is not responsible for any content contained on the page behind the link. Some tip search links need accounts or subscriptions with third parties in order to view the tip.